Programme

Lecture Theatre 1A
2022-09-03
15:50-17:05
Advances in IBD
15:50
The role of fecal calprotectin (FC) in IBD monitoring at home
16:15
Patients’ perspectives and expectations in the treatment of inflammatory bowel disease
16:40
Biosimilar
Lecture Theatre 1A
2022-09-03
17:05-18:20
Challenging GI bleeders
17:05
Endoscopy in patients receiving complex anti-thrombotic therapy
17:30
Management of difficult bleeders
17:55
Topic TBA
Lecture Theatre 1A
2022-09-04
09:00-10:30
Irritable Bowel Syndrome: Food, Poop and Drugs
09:00
Lifestyle and dietary advances in IBS management
09:30
FMT in IBS management: ready for prime time?
10:00
New drugs in IBS
Lecture Theatre 1A
2022-09-04
11:00-12:30
GI cancer: from prevention to cure
11:00
Non-invasive biomarkers for colorectal cancer: recent guidelines
11:30
Prevention of GI cancer: dream or reality?
12:00
What’s new in upper GI cancer treatment?
Lecture Theatre 1A
2022-09-04
13:30-14:30
Lunch Symposium (C)
13:30
The next stage of the ulcerative colitis (UC) journey
Advances in IBD
Lecture Theatre 1A
2022-09-03
15:50
15:50
The role of fecal calprotectin (FC) in IBD monitoring at home
16:15
Patients’ perspectives and expectations in the treatment of inflammatory bowel disease
16:40
Biosimilar
Challenging GI bleeders
Lecture Theatre 1A
2022-09-03
17:05
17:05
Endoscopy in patients receiving complex anti-thrombotic therapy
17:30
Management of difficult bleeders
17:55
Topic TBA
Irritable Bowel Syndrome: Food, Poop and Drugs
Lecture Theatre 1A
2022-09-04
09:00
09:00
Lifestyle and dietary advances in IBS management
09:30
FMT in IBS management: ready for prime time?
10:00
New drugs in IBS
GI cancer: from prevention to cure
Lecture Theatre 1A
2022-09-04
11:00
11:00
Non-invasive biomarkers for colorectal cancer: recent guidelines
11:30
Prevention of GI cancer: dream or reality?
12:00
What’s new in upper GI cancer treatment?
Lunch Symposium (C)
Lecture Theatre 1A
2022-09-04
13:30
13:30
The next stage of the ulcerative colitis (UC) journey